RF
LEGN icon

Roxbury Financial’s Legend Biotech LEGN Stock Holding History

Roxbury Financial’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-149
Closed -$3.24K – 402
2025
Q4 		$3.24K Hold
149
– – ﹤0.01% 330
2025
Q3 		$4.86K Hold
149
– – ﹤0.01% 315
2025
Q2 		$5.29K Buy
+149
New +$4.83K 0.01% 308

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
FBIL
First Beijing Investment Ltd Hong Kong $2.32B AUM 8.06% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Roxbury Financial's LEGN Position: Q1 2026 in Review

Roxbury Financial sold out of Legend Biotech (LEGN) in Q1 2026, closing a stake of 149 shares — an estimated $3.24K sold.

Roxbury Financial first reported a position in LEGN in Q2 2025 and held it in 3 quarters. The position peaked at $5.29K in Q2 2025. 190 funds tracked by Wall St. Rank hold LEGN as of Q1 2026.

  • Roxbury Financial reported no remaining Legend Biotech position as of Q1 2026 after selling out during the quarter.
  • Roxbury Financial sold 149 Legend Biotech shares in Q1 2026, an estimated $3.24K.
  • Roxbury Financial first reported a position in Legend Biotech in Q2 2025 and held it in 3 quarters.
  • Roxbury Financial's Legend Biotech position peaked at $5.29K in Q2 2025.
  • 190 funds tracked by Wall St. Rank held Legend Biotech as of Q1 2026.

Based on Roxbury Financial's 13F filing for Q1 2026, filed 17 Apr 2026.